Image via Forbes Innovation
Last updated
GoodRx: Product Launch
GoodRx launched GoodRx Companion, a $14.99/month membership covering prescriptions, dental, and online visits, positioning the company in the growing healthcare membership model segment.
Source: Forbes Innovation
The leadership read
A product move like this reshapes GoodRx's org chart as much as its roadmap. Scaling in the sector rests on product leadership that can carry a launch to adoption and commercial hires who turn early traction into pipeline. The Americas tell is whether senior GTM appointments follow; unsupported launches stall.
Market context: Against a Talent Market Index of 105.9 (Hot) (down 2.3 month-on-month), Americas is at rising (+2.4pts) on signal share.
GoodRx: 1 signal in the last 90 days.
MitchelLake in this thematic
More signals across Americas
Product Launch · Americas
Polaris →Polaris launched a virtual sleep clinic offering at-home sleep diagnostics and telehealth treatment coordination with sub-one-week diagnostic turnaround. Service covers sleep apnea diagnosis and referral to treatment vendors (CPAP, oral devices, hypoglossal nerve stimulators). Currently operational in DC, Maryland, and Virginia with stated plans for future regional expansion.
Product Launch · Americas
Sokin →Sokin, a global business payment solutions FinTech, disclosed first financials showing $90m run-rate net revenue (H1 2026) with 100%+ YoY growth. The company built and launched its own stablecoin infrastructure in 2026 and operates settlement rails across 36+ countries. Positioned Manchester United as official payment partner (August 2025).
Product Launch · Americas
Spring Fertility →Spring Fertility launched Personalized IVF Calculator, a first-of-its-kind tool providing personalized success probability information for fertility patients considering IVF treatment.
Product Launch · Americas
Inside Real Estate →Inside Real Estate launched Streams Studio, an industry AI platform designed to integrate with disparate brokerage systems, enabling any real estate brokerage to build AI solutions regardless of existing technology infrastructure.
Product Launch · Americas
Replimune →Replimune's melanoma drug candidate faced critical FDA reviewer skepticism, resulting in a 40% stock decline. Regulatory pathway likely requires additional data generation or trial redesign.
Product Launch · Americas
Navigate →Navigate launched a Health Dashboard platform connecting preventive and condition-specific care to measurable health outcomes, targeting employers to improve health results before insurance claims occur.
Intelligence powered by Autonodal ↗